[Vitamin E therapy in viral hepatitis].
Vitamin E therapy was compared with no treatment in a randomized, prospective trial for treatment of viral hepatitis in children. Patients received either vitamin E. (n:21), 300 mg./day intramuscularly every 24 hours, for seven days, or no treatment (n:20). The mean age (6.6 and 6.2), sex ratio, and the mean duration of illness before administration to study of two groups were similar. No difference was noted in the mean serum transaminases and alkaline phosphatase levels between both groups.
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002648:Child; D005260:Female; D006525:Hepatitis, Viral, Human / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011446:Prospective Studies; D011897:Random Allocation; D014810:Vitamin E / Q000627:therapeutic use*
D014810:Vitamin E; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase
Viral hepatitte vitamin E tedavisi.